2016
DOI: 10.1093/ageing/afw176
|View full text |Cite
|
Sign up to set email alerts
|

Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data

Abstract: 1Co-morbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data Word count: 2,303 Competing interestsWe declare the following interests: BG and GM report grants from the Chief Scientist Office ARPG 07/01 during the conduct of the study. Authors' ContributionsBG and SWM conceived the idea of the study. GMcL carried out statistical analysis and drafting of the results and methodology with BG. FC drafted literature review and interpreta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

11
127
1
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 120 publications
(151 citation statements)
references
References 29 publications
11
127
1
1
Order By: Relevance
“…In total, 91.6% of CCP had ≥ 4 active medications, 52.4% between 4-9, and 32.9% ≥ 10. The average use of 9.0 daily medications by our study participants is consistent with the existing literature [42,43], but it is high and concerning. On the other hand, polypharmacy is not just the use of multiple medications, but also and/or the administration of more medications than are clinically indicated, representing unnecessary drug use [44,45].…”
Section: Discussionsupporting
confidence: 91%
“…In total, 91.6% of CCP had ≥ 4 active medications, 52.4% between 4-9, and 32.9% ≥ 10. The average use of 9.0 daily medications by our study participants is consistent with the existing literature [42,43], but it is high and concerning. On the other hand, polypharmacy is not just the use of multiple medications, but also and/or the administration of more medications than are clinically indicated, representing unnecessary drug use [44,45].…”
Section: Discussionsupporting
confidence: 91%
“…An additional explanation for a longer LOS among PWD may be the functional and cognitive decline during hospitalization, which could prevent PWD from expressing their complaints to the medical staff including the occurrence of adverse drug reactions occurring in up to 11% of the hospital admissions . This is particularly relevant for PWD since they are more likely to be on 5 or more and 10 or more repeat prescriptions compared to PwoD . Furthermore, polypharmacy is a risk factor for emergency department attendance, hospitalization, and unplanned hospitalization among PWD, and among older adults, excessive polypharmacy is associated with staying more than 10 days in the hospital .…”
Section: Discussionmentioning
confidence: 99%
“…84 This is particularly relevant for PWD since they are more likely to be on 5 or more and 10 or more repeat prescriptions compared to PwoD. 85 Furthermore, polypharmacy is a risk factor for emergency department attendance, hospitalization, and unplanned hospitalization among PWD, 86 and among older adults, excessive polypharmacy is associated with staying more than 10 days in the hospital. 31 Also, the use of inadequate medication could lead to adverse events in PWD.…”
Section: Los In Hospitalizations Due To Infectious Cardiovascularmentioning
confidence: 99%
“…These highly stressful non‐cognitive symptoms are closely related to adverse outcomes, increased caregiving burden and healthcare costs . Furthermore, there is an increasing challenge of dementia overlapping with other geriatric syndromes, including polypharmacy, urinary incontinence, depression, falls and malnutrition . Screening and early intervention also play important roles in dementia care.…”
Section: Introductionmentioning
confidence: 99%